← Back to headlines
Pfizer Raises 2026 Guidance Despite COVID-19 Sales Decline
Pfizer has managed to raise its 2026 financial guidance, overcoming a tumble in sales related to its COVID-19 products.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
